Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
University of Toronto
$100,000.00
Multiplexed assay for variant interpretation in human oncogenes using a humanized yeast model
FY 2022-23
Summary
The vision of a healthcare system guided by information in our individual genomes is currently limited by a major challenge: Our current inability to distinguish whether genomic sequence variants are benign or pathogenic. Indeed, sequencing of patients with a known familial history of cancer frequently only discover variants with no known clinical interpretation (also known as variants of uncertain significance, or VUS). We can now experimentally test variant function at large-scale, by generating every possible amino acid substitution in genes of interest and assaying the effects of those mutations in a suitable model system. However, this has only been performed for fewer than 1% of disease genes. Here, we propose to systematically perform this experiment for human cancer-related genes (oncogenes) in a humanized-yeast system. We leverage the property that dysfunction of oncogenes frequently leads to increased genetic mutation rate and develop a novel assay to quantify this genetic mutation rate at extremely high throughput. Finally, we develop robotic and computational approaches to automate the process of making all possible mutations in genes in a cost-efficient manner to scale the experimental design to all human oncogenes that can be assayed in yeast. After calibrating experimental results with known clinical variants, pathogenic variants will be made available as a 'map' to guide future disease management. Our project will provide new understanding of oncogenes and provide experimental tools to inform on human biology.
Department
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
472629
Name
Nguyen Ba Alex N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Multiplexed assay for variant interpretation in human oncogenes using a humanized yeast model
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Automation; Bioinformatics; Clinical Genetics And Diagnosis; Etiology Of Cancer Disease; Model Organism; Molecular And Functional Genetics; Next-Generation Sequencing; Synthetic Biology
Abstract
The vision of a healthcare system guided by information in our individual genomes is currently limited by a major challenge: Our current inability to distinguish whether genomic sequence variants are benign or pathogenic. Indeed, sequencing of patients with a known familial history of cancer frequently only discover variants with no known clinical interpretation (also known as variants of uncertain significance, or VUS). We can now experimentally test variant function at large-scale, by generating every possible amino acid substitution in genes of interest and assaying the effects of those mutations in a suitable model system. However, this has only been performed for fewer than 1% of disease genes. Here, we propose to systematically perform this experiment for human cancer-related genes (oncogenes) in a humanized-yeast system. We leverage the property that dysfunction of oncogenes frequently leads to increased genetic mutation rate and develop a novel assay to quantify this genetic mutation rate at extremely high throughput. Finally, we develop robotic and computational approaches to automate the process of making all possible mutations in genes in a cost-efficient manner to scale the experimental design to all human oncogenes that can be assayed in yeast. After calibrating experimental results with known clinical variants, pathogenic variants will be made available as a 'map' to guide future disease management. Our project will provide new understanding of oncogenes and provide experimental tools to inform on human biology.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nguyen Ba, Alex N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~